Noah AI Industry News

Delivers real-time biopharma news and signals — powered by AI, curated for professionals.

Pelage Pharmaceuticals Secures $120 Million for Innovative Hair Loss Treatment

Pelage Pharmaceuticals, a Los Angeles-based startup, has successfully closed a $120 million Series B funding round to advance its novel topical gel therapy for hair loss. The fundraising effort, led by Arch Venture Partners and GV (formerly Google Ventures), underscores growing interest in regenerative approaches to treating alopecia.

NoahAI News10/16/2025

Town Hall Ventures Raises $440M for AI-Focused Health Equity Fund

Town Hall Ventures (THV) has announced the successful raise of $440 million for its fourth fund, marking a significant step in the venture capital firm's mission to support innovative healthcare solutions for underserved communities. The new fund will focus on AI-first companies that aim to revolutionize care delivery and accessibility in less-resourced areas.

NoahAI News10/16/2025

AstraZeneca Invests $445 Million to Boost Lokelma Production in Texas

AstraZeneca has announced a significant $445 million investment to expand production capabilities for its hyperkalemia treatment, Lokelma, at its manufacturing facility in Coppell, Texas. This move comes as part of the company's broader $50 billion investment strategy in the United States over the next five years.

NoahAI News10/16/2025

GSK and Scynexis Resolve Brexafemme Trial Dispute with $22M Settlement

GSK and Scynexis have reached a resolution in their dispute over the phase 3 MARIO study of antifungal drug Brexafemme (ibrexafungerp) in invasive candidiasis. The agreement involves a $22 million payment from GSK to Scynexis and the winding down of the clinical trial.

NoahAI News10/16/2025

Lapsi Health Launches Keikku 2.0: AI-Powered Smart Stethoscope Revolutionizes Clinical Workflow

Lapsi Health, a pioneering health tech company, has unveiled the second generation of its digital smart stethoscope, Keikku 2.0, integrating advanced AI capabilities to function as an intelligent assistant for physicians across multiple specialties. This innovative device combines clinical, administrative, and AI power in a single tool, marking a significant leap forward in medical technology.

NoahAI News10/16/2025

Prospect Medical Holdings to Sell Two Shuttered Pennsylvania Hospitals for $13M

Prospect Medical Holdings, a for-profit healthcare system, has reached tentative agreements to sell two of its closed hospitals in Pennsylvania for a combined $13 million. This development marks a significant step in the company's ongoing bankruptcy proceedings and could potentially conclude a tumultuous chapter in Delaware County's healthcare landscape.

NoahAI News10/16/2025

Breakthrough Alzheimer's Research Podcast Series Explores Latest Developments

In a groundbreaking four-part podcast series titled "The Progress Profile: Alzheimer's Research in Focus," leading experts in neurodegenerative disease research come together to discuss the latest advancements in Alzheimer's diagnosis, treatment, and prevention. The series, hosted by cognition expert Dr. John Harrison, features insights from renowned scientists and offers a comprehensive overview of the current state of Alzheimer's research.

NoahAI News10/16/2025

Diabetes Drug Metformin Shows Promise in Treating Multiple Sclerosis in Women

A groundbreaking study published in Science Translational Medicine on October 15, 2025, reveals that metformin, a common diabetes medication, may have potential in treating multiple sclerosis (MS) in women. The research, led by Dr. Rhonda Voskuhl at the University of California, Los Angeles (UCLA), demonstrates that metformin alleviates brain inflammation in female mice with MS, opening new avenues for sex-specific treatments in autoimmune diseases.

NoahAI News10/16/2025

Garnet Health and Montefiore Health System Explore Potential Affiliation

In a significant development for New York's healthcare landscape, Garnet Health and Montefiore Health System have signed a letter of intent to explore a potential affiliation. This move could result in the creation of a 13-hospital network, combining Garnet's three hospitals with Montefiore's existing ten facilities.

NoahAI News10/16/2025

J&J's Tecvayli-Darzalex Combo Shows Promise in Multiple Myeloma Treatment

Johnson & Johnson (J&J) has announced significant progress in the treatment of multiple myeloma, with its combination therapy of Tecvayli and Darzalex Faspro demonstrating positive results in late-stage clinical trials. The pharmaceutical giant is now preparing to present its findings to health authorities, potentially expanding the treatment options for patients with this rare form of blood cancer.

NoahAI News10/16/2025

Sarepta Pushes Forward with Gene Therapy for LGMD Despite Regulatory Hurdles

Sarepta Therapeutics, a company known for its gene therapy developments, is continuing to pursue its investigational treatment for limb-girdle muscular dystrophy (LGMD) despite recent setbacks and a strategic pivot towards siRNA therapies. The company's perseverance with SRP-9003, its LGMD gene therapy candidate, comes amid significant regulatory challenges and safety concerns that have shaken the biotech's gene therapy platform.

NoahAI News10/15/2025

Pelage Pharmaceuticals Secures $120 Million for Innovative Hair Loss Treatment

Pelage Pharmaceuticals has successfully raised $120 million in a Series B financing round to advance its novel hair loss treatment program. The substantial investment will fuel the progression of the company's lead molecule, PP405, into Phase III clinical trials scheduled for 2026. This development marks a significant milestone in the pursuit of more effective solutions for androgenetic alopecia, a common form of hair loss affecting both men and women.

NoahAI News10/15/2025

«1...39 40 41...67 »